BioSpace News Archive

Drug Development

Eli Lilly’s Olumiant Becomes First Systemic Treatment for Alopecia Areata

Eli Lilly’s Olumiant (baricitinib) received approval from the FDA for the treatment of severe alopecia areata, making it the first systemic treatment for adults living with the disease.

June 14, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Soleno Soars on Positive Prader-Willi Syndrome Data

Soleno announced promising results of its diazoxide choline extended-release tablets in patients with Prader-Willi syndrome at ENDO 2022.

June 14, 2022
·
3 min read
·
Tristan Manalac
Business

On a Partnering Spree, Evotec Announces New Janssen Alliance

Evotec SE has inked a deal with Janssen Pharmaceutical hat showcases its end-to-end integrated drug discovery and development platform.

June 14, 2022
·
2 min read
·
Alex Keown
Drug Development

Alnylam Scores Another FDA Nod in hATTR

The FDA has approved Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults.

June 14, 2022
·
3 min read
·
Mark Terry
Policy

FDA Agrees to Meet with Stealth on Barth Syndrome Drug

On Tuesday, Stealth Biotherapeutics announced that it plans to meet with the FDA to discuss a potential NDA for its therapeutic, elamipretide, which is intended to treat Barth syndrome.

June 14, 2022
·
2 min read
·
Hayley Shasteen
Researchers Link Mutations in Long Neglected Non-Coding Genome to Cancer

Researchers from the Dana-Farber Cancer Institute looked deeper into a non-coding portion of the human genome, uncovering mechanisms that might drive or suppress cancer development.

June 14, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Day One Bio Reports Mid-Stage Success in Childhood Brain Cancer

Day One Biopharmaceuticals announced positive early data assessing tovorafenib as a once-a-week treatment in people aged six months to 25 years with relapsed or progressive pediatric low-grade glioma.

June 14, 2022
·
3 min read
·
Mark Terry
Biotech Beach

BIO Returns to San Diego with Innovation and Partnering on the Menu

The annual BIO convention has returned, bringing thousands of life sciences companies worldwide to the annual networking event that could spark collaborations and deals.

June 14, 2022
·
3 min read
·
Alex Keown
Business

Pfizer, MorphoSys and Incyte Take Aim at DLBCL in New Collab

MorphoSys U.S. Inc., Pfizer and Incyte are teaming up to test Pfizer’s TTI-622 in conjunction with Monjuvi plus lenalidomide in patients with lymphoma.

June 14, 2022
·
3 min read
·
Hannah Chudleigh
Policy

UPDATE: In Unanimous Vote, FDA Advisory Committee Recommends Moderna’s COVID Vaccine for Kids 6-17

In a unanimous vote, a panel of FDA advisors voted to recommend the approval of Moderna’s COVID-19 vaccine for children between the ages of six and 17 years old.

June 14, 2022
·
2 min read
·
Alex Keown